Related Experiment Video
Updated: May 10, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Loss of Jak2 impairs endothelial function by attenuating Raf-1/MEK1/Sp-1 signaling along with altered eNOS activities
Ping Yang1, Yawen Zhang, Junfeng Pang
1Center for Biomedical Research, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Abstract:
A number of inhibitors have been used to dissect the functional relevance of Jak2 in endothelial homeostasis, with disparate results. Given that Jak2 deficiency leads to embryonic lethality, the exact role of Jak2 in the regulation of postnatal endothelial function is yet to be fully elucidated. We generated a model in which Jak2 deficiency can be induced by tamoxifen in adult mice. Loss of Jak2 significantly impaired endothelium-dependent response capacity for vasodilators. Matrigel plug assays indicated a notable decrease in endothelial angiogenic function in Jak2-deficient mice. Studies in a hindlimb ischemic model indicated that Jak2 activity is likely to be a prerequisite for prompt perfusion recovery, based on the concordance of temporal changes in Jak2 expression during the course of ischemic injury and perfusion recovery. A remarkable delay in perfusion recovery, along with reduced capillary and arteriole formation, was observed in Jak2-deficient mice. Antibody array studies indicated that loss of Jak2 led to repressed eNOS expression. In mechanistic studies, Jak2 deficiency attenuated Raf-1/MEK1 signaling, which then reduced activity of Sp-1, an essential transcription factor responsible for eNOS expression. These data are important not only for understanding the exact role that Jak2 plays in endothelial homeostasis, but also for assessing Jak2-based therapeutic strategies in a variety of clinical settings.
Insights
Janus kinase 2 (Jak2) is crucial for adult blood vessel function. Loss of Jak2 impairs blood vessel relaxation, growth, and repair after injury, impacting endothelial homeostasis and recovery.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Physiology
Background:
- The precise role of Janus kinase 2 (Jak2) in maintaining adult endothelial homeostasis remains unclear due to conflicting results from inhibitor studies.
- Jak2 deficiency causes embryonic lethality, necessitating models to study its postnatal functions in endothelial cells.
Purpose of the Study:
- To elucidate the specific role of Jak2 in regulating postnatal endothelial function and homeostasis.
- To investigate the impact of Jak2 deficiency on vascular responses, angiogenesis, and ischemic injury recovery.
Main Methods:
- Generation of a tamoxifen-inducible Jak2-deficient adult mouse model.
- Assessment of endothelium-dependent vasodilation, in vivo angiogenesis using Matrigel plug assays, and hindlimb ischemia models.
- Analysis of perfusion recovery, neovascularization, and expression of key proteins like eNOS via antibody arrays and signaling pathway analysis.
Main Results:
- Jak2 deficiency significantly impaired endothelium-dependent vasodilation and reduced angiogenic capacity.
- Loss of Jak2 delayed perfusion recovery in a hindlimb ischemia model, with decreased capillary and arteriole formation.
- Jak2 deficiency repressed eNOS expression by attenuating the Raf-1/MEK1/Sp-1 signaling pathway.
Conclusions:
- Jak2 is essential for normal postnatal endothelial function, including vasodilation, angiogenesis, and ischemic repair.
- The Jak2-eNOS pathway, involving Raf-1/MEK1/Sp-1 signaling, is critical for endothelial homeostasis and vascular recovery.
- Targeting Jak2 may offer therapeutic potential for conditions involving vascular dysfunction.
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
